Description
AOD9604 peptide research material is supplied for laboratory and non-clinical investigation of AOD9604, a modified fragment of the human growth hormone molecule (amino acids 176-191) studied extensively in lipid-metabolism research models.
What Is AOD9604
AOD9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone, modified to isolate the region associated with lipid metabolism while excluding the growth-promoting region of the full HGH molecule. AOD9604 peptide research material is used by laboratories investigating lipolysis pathways, adipocyte signaling, and metabolic regulation across in vitro and animal-model research systems.
Research Applications (laboratory / non-clinical research only)
- Animal model research into lipolysis and adipocyte metabolism pathways
- In vitro studies of fat-cell signaling and triglyceride breakdown mechanisms
- Preclinical investigation of metabolic rate regulation in rodent models
- Comparative research into AOD9604 versus full-length growth-hormone research compounds
- Laboratory studies of cartilage and connective-tissue research models
Quality & Sourcing
AOD9604 peptide research material is manufactured to high purity standards and verified by HPLC (High-Performance Liquid Chromatography) analysis. Each batch is lyophilized for stability, and a Certificate of Analysis (COA) is available on request confirming peptide identity and purity. Material is intended for use by qualified researchers in controlled laboratory environments only.
Supplied As
Supplied as a lyophilized 10mg vial, suitable for standard laboratory reconstitution procedures performed by trained personnel for research purposes.
Molecular Characteristics
AOD9604 is a 16-amino-acid fragment corresponding to the C-terminal region of human growth hormone (amino acids 176-191), modified to exclude the region responsible for growth-promoting activity while retaining the region associated with lipid metabolism research. This truncation results in a considerably smaller molecule than full-length HGH, which researchers note is generally easier to synthesize to high purity and formulate as a stable lyophilized powder. The modified structure is intended to isolate a specific region of interest for targeted metabolic research.
Handling & Storage Considerations
Lyophilized AOD9604 should be stored in a freezer (-20°C or below), protected from light and moisture, until reconstitution is needed for a laboratory protocol. Once reconstituted with bacteriostatic water, the solution is generally stored refrigerated (2-8°C) and used within the window supported by internal stability testing. As with other growth-hormone-fragment peptides, repeated freeze-thaw cycles and prolonged room-temperature exposure are generally avoided to preserve research-grade integrity.
Common Research Design Considerations
Laboratories investigating AOD9604 commonly design animal-model studies evaluating lipolysis and adipocyte metabolism, often measuring triglyceride breakdown and fat-cell signaling markers in rodent models. In vitro research frequently uses adipocyte cell culture systems to assess metabolic rate regulation and fat-cell signaling responses. Comparative study designs often examine AOD9604 alongside full-length growth-hormone research compounds to characterize differences between the isolated fragment and the complete hormone molecule within the same laboratory program.
Frequently Asked Questions
Is this compound stable at room temperature?
Short-term handling at room temperature during active laboratory use is generally acceptable, but frozen storage is recommended between research sessions to preserve peptide integrity.
What purity level should researchers expect?
Material is verified by HPLC analysis at the time of batch testing, with purity data available via the accompanying Certificate of Analysis.
Is a Certificate of Analysis provided?
Yes, a COA is available on request for each batch, confirming identity and purity for research documentation purposes.
Related Compounds
Researchers investigating AOD9604 often also study other metabolic and weight-management-focused research peptides such as Tirzepatide and Retatrutide, comparing fragment-based and receptor-agonist approaches within the same laboratory program. AOD9604 is also occasionally referenced alongside GLP-1 and GIP receptor agonist compounds in review literature discussing distinct mechanisms of metabolic pathway research.
For research use only. Not for human or veterinary use. Not a drug, supplement, or therapeutic product. Not intended to diagnose, treat, cure, or prevent any condition.
